Cell therapy · clinical evidence
CAR-iTNK — Understand the evidence before considering treatment
CAR-iTNK relates to research involving immune-cell engineering and NK-like properties. A research term is not proof of an available routine cancer treatment.
What is the evidence?
Ask for a specific protocol, cell source, registered study, published data and patient selection requirements.
Safety and limitations
Risks and monitoring depend on the exact research procedure; do not assume CAR-T safety profiles or outcomes apply unchanged.
What should be assessed?
The diagnosis, research protocol, inclusion and exclusion rules, performance status and study-site availability.